193 related articles for article (PubMed ID: 22004797)
41. Sphingosine kinase inhibitor suppresses a Th1 polarization via the inhibition of immunostimulatory activity in murine bone marrow-derived dendritic cells.
Jung ID; Lee JS; Kim YJ; Jeong YI; Lee CM; Baumruker T; Billlich A; Banno Y; Lee MG; Ahn SC; Park WS; Han J; Park YM
Int Immunol; 2007 Apr; 19(4):411-26. PubMed ID: 17307797
[TBL] [Abstract][Full Text] [Related]
42. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
43. Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability.
Dzopalic T; Dragicevic A; Vasilijic S; Vucevic D; Majstorovic I; Bozic B; Balint B; Colic M
Int Immunopharmacol; 2010 Nov; 10(11):1428-33. PubMed ID: 20817120
[TBL] [Abstract][Full Text] [Related]
44. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
45. Cholecystokinin octapeptide exerts its therapeutic effects on collagen-induced arthritis by suppressing both inflammatory and Th17 responses.
Li Q; Cong B; Shan B; Zhang J; Chen H; Wang T; Ma C; Qin J; Wen D; Yu F
Rheumatol Int; 2011 Oct; 31(10):1291-8. PubMed ID: 20376668
[TBL] [Abstract][Full Text] [Related]
46. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.
Lo CK; Lam QL; Sun L; Wang S; Ko KH; Xu H; Wu CY; Zheng BJ; Lu L
Arthritis Rheum; 2008 Sep; 58(9):2700-11. PubMed ID: 18759269
[TBL] [Abstract][Full Text] [Related]
47. Effect of 1,25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behçet's disease.
Tian Y; Wang C; Ye Z; Xiao X; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6434-41. PubMed ID: 22918640
[TBL] [Abstract][Full Text] [Related]
48. Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints.
Miyamoto Y; Uga H; Tanaka S; Kadowaki M; Ikeda M; Saegusa J; Morinobu A; Kumagai S; Kurata H
Mol Immunol; 2013 Jun; 54(2):199-207. PubMed ID: 23287598
[TBL] [Abstract][Full Text] [Related]
49. Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis.
Yoshiga Y; Goto D; Segawa S; Horikoshi M; Hayashi T; Matsumoto I; Ito S; Taniguchi M; Sumida T
Clin Exp Immunol; 2011 May; 164(2):236-47. PubMed ID: 21391989
[TBL] [Abstract][Full Text] [Related]
50. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
51. Cryptomerione induces Th1 cell polarization via influencing IL-10 production by cholera toxin-primed dendritic cells.
Takei M; Umeyama A; Lee JJ; Shoji N; Hashimoto T
Eur J Pharmacol; 2010 Feb; 628(1-3):233-9. PubMed ID: 19941850
[TBL] [Abstract][Full Text] [Related]
52. Tyk2 deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice.
Ishizaki M; Muromoto R; Akimoto T; Ohshiro Y; Takahashi M; Sekine Y; Maeda H; Shimoda K; Oritani K; Matsuda T
Int Immunol; 2011 Sep; 23(9):575-82. PubMed ID: 21765170
[TBL] [Abstract][Full Text] [Related]
53. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
[TBL] [Abstract][Full Text] [Related]
54. C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation.
Teh BK; Yeo JG; Chern LM; Lu J
Mol Immunol; 2011 May; 48(9-10):1128-38. PubMed ID: 21429584
[TBL] [Abstract][Full Text] [Related]
55. IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells.
Lexberg MH; Taubner A; Albrecht I; Lepenies I; Richter A; Kamradt T; Radbruch A; Chang HD
Eur J Immunol; 2010 Nov; 40(11):3017-27. PubMed ID: 21061434
[TBL] [Abstract][Full Text] [Related]
56. Periplocoside A ameliorated type II collagen-induced arthritis in mice via regulation of the balance of Th17/Treg cells.
Yang Y; Hu X; Cheng L; Tang W; Zhao W; Yang Y; Zuo J
Int Immunopharmacol; 2017 Mar; 44():43-52. PubMed ID: 28073043
[TBL] [Abstract][Full Text] [Related]
57. Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice.
Lee YC; Kim SH; Roh SS; Choi HY; Seo YB
J Ethnopharmacol; 2007 May; 112(1):40-8. PubMed ID: 17353105
[TBL] [Abstract][Full Text] [Related]
58. Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response.
You X; Pan M; Gao W; Shiah HS; Tao J; Zhang D; Koumpouras F; Wang S; Zhao H; Madri JA; Baker D; Cheng YC; Yin Z
Arthritis Rheum; 2006 Mar; 54(3):877-86. PubMed ID: 16508970
[TBL] [Abstract][Full Text] [Related]
59. Kurarinone Attenuates Collagen-Induced Arthritis in Mice by Inhibiting Th1/Th17 Cell Responses and Oxidative Stress.
Tang KT; Lin CC; Lin SC; Wang JH; Tsai SW
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924467
[TBL] [Abstract][Full Text] [Related]
60. Suppressive effect of hochu-ekki-to on collagen induced arthritis in DBA1J mice.
Hai le X; Kogure T; Niizawa A; Fujinaga H; Sakakibara I; Shimada Y; Watanabe H; Terasawa K
J Rheumatol; 2002 Aug; 29(8):1601-8. PubMed ID: 12180716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
